Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...
THREE of the most dangerous medicines in the world have been revealed – and millions of Brits already use them. A cold and ...
Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
18h
Irish Examiner on MSNNasal irrigation: Breathe easy by flushing out your nasal cavityNasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results